Eli Lilly and Company Website

Eli Lilly and Company

NYSE-LLY

Basic

  • Market Cap

    —

  • EV

    —

  • Shares Out

    —

  • Revenue

    $40.86B

  • Employees

    43,000

Margins

  • Gross

    80.91%

  • EBITDA

    40.54%

  • Operating

    36.46%

  • Pre-Tax

    24.84%

  • Net

    20.48%

  • FCF

    3.43%

Returns (5Yr Avg)

  • ROA

    12.79%

  • ROTA

    -620.2%

  • ROE

    90.67%

  • ROCE

    25.91%

  • ROIC

    20.8%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    —

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $3,518.4M

  • Net Debt

    $27.16B

  • Debt/Equity

    2.18

  • EBIT/Interest

    21.46

Growth (CAGR)

  • Rev 3Yr

    13.76%

  • Rev 5Yr

    13.35%

  • Rev 10Yr

    7.25%

  • Dil EPS 3Yr

    12.19%

  • Dil EPS 5Yr

    2.3%

  • Dil EPS 10Yr

    13.99%

  • Rev Fwd 2Yr

    —

  • EBITDA Fwd 2Yr

    —

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    —

Dividends

  • Yield

    —

  • Payout

    54.13%

  • DPS

    $5.03

  • DPS Growth 3Yr

    15.2%

  • DPS Growth 5Yr

    15.03%

  • DPS Growth 10Yr

    9.88%

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Operating Revenues

22,319.5

24,539.8

28,318.4

28,541.4

34,124.1

40,863.3

Total Revenues

22,319.5

24,539.8

28,318.4

28,541.4

34,124.1

40,863.3

Total Revenues % Chg.

3.8%

9.9%

15.4%

0.8%

19.6%

27.4%

Cost of Goods Sold, Total

4,721.2

5,483.3

6,973.1

6,629.8

7,082.2

7,802.5

Gross Profit

17,598.3

19,056.5

21,345.3

21,911.6

27,041.9

33,060.8

Selling General & Admin Expenses, Total

6,003.9

5,869.4

6,141.9

6,067.5

6,941.2

7,633

R&D Expenses

5,595

5,976.3

6,930.7

7,190.8

9,313.4

10,530.8

Other Operating Expenses, Total

11,598.9

11,845.7

13,072.6

13,258.3

16,254.6

18,163.8

Operating Income

5,999.4

7,210.8

8,272.7

8,653.3

10,787.3

14,897

Interest Expense, Total

-400.6

-359.6

-339.8

-331.6

-485.9

-694.1

Interest And Investment Income

80.4

33

25.4

62.8

173.6

175.4

Net Interest Expenses

-320.2

-326.6

-314.4

-268.8

-312.3

-518.7

Currency Exchange Gains (Loss)

-61.9

123.7

-204.6

-191.3

-26.4

117.6

Other Non Operating Income (Expenses)

5.3

-319.2

256

177

-6.3

-139.1

EBT, Excl. Unusual Items

5,622.6

6,688.7

8,009.7

8,370.2

10,442.3

14,356.8

Restructuring Charges

-77.8

-151.2

-13

-23

-45.5

-45.5

Merger & Related Restructuring Charges

—

—

—

—

—

-400.7

—

—

—

—

—

Gain (Loss) On Sale Of Investments

—

401.2

1,442.2

176.9

-410.7

-20.2

91.8

Gain (Loss) On Sale Of Assets

—

—

—

—

309.8

—

—

—

—

—

Asset Writedown

—

—

—

—

—

—

—

—

—

—

In Process R&D Expenses

-239.6

-769.8

-970.1

-908.5

-3,799.8

-3,713.8

Other Unusual Items

-349.6

20

-1,048

-221.6

-22.2

-538.8

EBT, Incl. Unusual Items

5,265.9

7,229.9

6,155.5

6,806.4

6,554.6

10,150.5

Income Tax Expense

628

1,036.2

573.8

561.6

1,314.2

1,780.6

Earnings From Continuing Operations

4,637.9

6,193.7

5,581.7

6,244.8

5,240.4

8,369.9

Earnings Of Discontinued Operations

—

—

—

3,680.5

—

—

—

—

—

Net Income

8,318.4

6,193.7

5,581.7

6,244.8

5,240.4

8,369.9

Net Income to Common Incl Extra Items

8,318.4

6,193.7

5,581.7

6,244.8

5,240.4

8,369.9

Net Income to Common Excl. Extra Items

4,637.9

6,193.7

5,581.7

6,244.8

5,240.4

8,369.9

Total Shares Outstanding

907.5

906.6

903.7

900.2

899.4

899.9

Weighted Avg. Shares Outstanding

931.1

907.6

907

901.7

900.2

900.7

Weighted Avg. Shares Outstanding Dil

935.7

912.5

911.7

904.6

903.3

904.3

EPS

8.9

6.8

6.2

6.9

5.8

9.3

EPS Diluted

8.9

6.8

6.1

6.9

5.8

9.2

EBITDA

7,232

8,534.7

9,820.3

10,175.8

12,314.6

16,566.5

Effective Tax Rate

11.9%

14.3%

9.3%

8.3%

20.1%

17.5%